.png)
CUNY, Lehman College
Working as a statistical scientist for more than 30 years in the medical/public health fields, John Orazem has contributed to drug development in diverse therapeutic areas, incorporating adaptive designs that permit early termination, innovative simulation-based approaches to sample size determination, and novel methods to assess the impact of missing data. He designed causal models to investigate medical record databases, and his current work is focused on analyzing complex secondary data sources.
Financial Disclosure:
•No, I do not have financial relationships relevant to the content of the session.
Non-financial Disclosures:
•No, I do not have non financial relationships relevant to the content of the session.
These disclosures apply to all presentations listed below.